Furthermore, LY294002 single treatment at different concentrations (1, 5 and 10 μM) up-regulated apoptotic cells in a dose-dependent manner, indicating that PI3K/AKT was indeed involved in lung cancer growth, which could be modulated for juglanin (Supplementary Figure 1C). This evidence concerns the gene AKT1 and lung carcinoma.